About this trial
This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria.
These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies.
It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered
Patient admitted between 1st January 2012 to 31st December 2017
Disqualifiers
None
Trial population
All patients treated in medical and surgical resuscitation units of Besançon and Dijon university hospitals during the study period (from 01/01/2012 to 31/12/2017) are concerned.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Survival at 90 days after leaving ICU
All-cause mortality 90 days after leaving ICU
Sponsors and contacts
Click on the lead sponsor to view all of their trials.